Search results
Results from the WOW.Com Content Network
The Zika Authorization Plan Act of 2016 (H.R. 4562) was a bill introduced in the second session of the United States 114th Congress by Representative Curt Clawson (R-FL) on February 12, 2016. [ 1 ] [ 2 ] The bill was prompted by the Zika virus health scare and was aimed at reducing the spread of the virus.
Crimean-Congo hemorrhagic fever virus; Ebola virus; Lassa virus; Lujo virus; Marburg virus; New World arenavirus – Guanarito virus; New World arenavirus – Junin virus; New World arenavirus – Machupo virus; New World arenavirus – Sabia virus; Yellow fever; Zika virus disease and Zika virus infection Zika virus disease, congenital
Download as PDF; Printable version; In other projects Wikidata item; Appearance. move to sidebar hide. Zika virus outbreak may refer to: 2015–2016 Zika virus ...
During the 2002–2004 SARS outbreak, the SARS-CoV-1 virus was prevented from causing a pandemic of Severe acute respiratory syndrome (SARS). Rapid action by national and international health authorities such as the World Health Organization helped to slow transmission and eventually broke the chain of transmission, which ended the localized epidemics before they could become a pandemic.
Zika fever (also known as Zika virus disease) is an illness caused by Zika virus. [80] Around 80% of cases are estimated to be asymptomatic, though the accuracy of this figure is hindered by the wide variance in data quality, and figures from different outbreaks can vary significantly. [ 81 ]
Zika virus vaccine clinical trials are to be conducted and established. There are efforts being put toward advancing antiviral therapeutics against zika virus for swift control. Present day Zika virus treatment is symptomatic through antipyretics and analgesics. Currently there are no publications regarding viral drug screening.
NCIRD supports and supervises state and local agencies working on immunization activities and commercial contracting for vaccine supply and distribution. NCIRD supports a national framework for surveillance of diseases for which immunizing agents are increasingly becoming available from commercial pharmaceutical companies, and assists health departments in developing vaccine information ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Coronavirus disease 2019 (COVID-19) Yes: Coxsackie B virus: Coxsackie B virus infection Enterovirus infection is diagnosed mainly via serological tests such as ELISA and from cell culture. There is no well-accepted treatment for the Coxsackie B group of viruses. Under research [10] PRNP